The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Intra-articular injection of monoiodoacetate induces diverse hip osteoarthritis in rats, depending on its dose
Open accessAbstract
Background: Monoiodoacetate (MIA)-induced arthritis models are used widely in osteoarthritis (OA) research to develop effective conservative treatments for hip OA, as an alternative to joint replacement surgery. In joint OA models, such as the MIA-induced knee OA model, various doses of MIA are utilized, depending on the purpose of the research. So far, only 2 mg of MIA has been used for MIA-induced hip OA research. We hypothesized that the amount of MIA should be adjusted according to the osteoarthritis model under investigation. We performed radiographic and histological evaluations in rats for hip OA models induced by different doses of MIA. Methods: One hundred and eighty right hips of six-week-old, male Sprague–Dawley rats (n = 30 rats per group) were treated with either a single intra-articular injection of various doses of MIA (0.25, 0.5, 1.0, 2.0, and 4.0 mg) dissolved in 25 μl of sterile saline (MIA group), or with 25 μl of sterile saline alone (Sham group). Radiographic and histological evaluations of the hip joint were performed at one, two, four, eight, and 12 weeks after administration (n = 6 rats per group per time point). Results: OA changes progressed from 1 week after administration in the 1.0-mg, 2.0-mg, and 4.0-mg MIA groups. The degree of OA changes increased as the dose of MIA increased. The 0.25-mg and 0.5-mg MIA groups presented fewer OA changes than the 2.0-mg and 4.0-mg MIA groups during the entire study period (up to 12 weeks). The administration of 0.25 mg and 0.5 mg of MIA-induced both radiographic and histological OA changes in a time-dependent manner, whereas more than 2 mg of MIA provoked end-stage OA at 8 weeks after injection. Absolute, dose-dependent histopathological OA changes were observed 4 weeks after MIA administration. Conclusions: Intra-articular MIA injection to the hip joints of rats induced diverse OA changes dose-dependently. Research for developing novel conservative treatments for hip OA and intractable pain should consider the pathological condition when determining the dose of MIA to be employed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These findings provide scientific evidence for developing new OA treatment strategies, confirming the potential of GLP-1 agonists in treating OA.315–317”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [316]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The results showed that, in the OA rat model, liraglutide could activate the PKA/CREB signaling pathway and inhibit the inflammatory response through this pathway, thereby alleviating OA symptoms.316”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [316]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiological Assessment of Osteo-Arthrosis
Kellgren, J. H., & Lawrence, J. S. (1957) · Annals of the Rheumatic Diseases · doi:10.1136/ard.16.4.494 · Cited by 12,422
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
Cross, M., Smith, E., Hoy, D., Nolte, S., Ackerman, I., Fransen, M., Bridgett, L., Williams, S., Guillemin, F., Hill, C. L., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204763 · Cited by 3,496
Osteoarthritis cartilage histopathology: grading and staging
Pritzker, K. P. H., Gay, S., Jimenez, S. A., Ostergaard, K., Pelletier, J.-P., Revell, P. A., Salter, D., & van den Berg, W. B. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.07.014 · Cited by 2,340
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Griffith, J. W., Sokol, C. L., & Luster, A. D. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120145 · Cited by 2,059
Inflammation in osteoarthritis
Goldring, M. B., & Otero, M. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328349c2b1 · Cited by 1,462
JORDAN, J. M., HELMICK, C. G., RENNER, J. B., LUTA, G., DRAGOMIR, A. D., WOODARD, J., FANG, F., SCHWARTZ, T. A., NELSON, A. E., ABBATE, L. M., et al. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.080677 · Cited by 739
Effect of Three Types of Mixed Anesthetic Agents Alternate to Ketamine in Mice
KAWAI, S., TAKAGI, Y., KANEKO, S., & KUROSAWA, T. (2011) · Experimental Animals · doi:10.1538/expanim.60.481 · Cited by 580
Guzman, R. E., Evans, M. G., Bove, S., Morenko, B., & Kilgore, K. (2003) · Toxicologic Pathology · doi:10.1080/01926230390241800 · Cited by 461
Epidemiology of osteoarthritis: an update
Sharma, L., Kapoor, D., & Issa, S. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000209426.84775.f8 · Cited by 430
Cited by
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
Arai, T., Suzuki-Narita, M., Takeuchi, J., Tajiri, I., Inage, K., Kawarai, Y., Eguchi, Y., Shiga, Y., Hozumi, T., Kim, G., et al. (2022) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-022-05937-y · Cited by 14
Self-citation
Metadata
- Authors
- Yoh, S., Kawarai, Y., Hagiwara, S., Orita, S., Nakamura, J., Miyamoto, S., Suzuki, T., Akazawa, T., Shiko, Y., Kawasaki, Y., & Ohtori, S.
- Affiliations
- Chiba University (JP)
- Matsudo City Hospital (JP)
- St. Marianna University School of Medicine (JP)
- Chiba University Hospital (JP)
- Corresponding author
- Kawarai, Yuya
- ORCID
- Venue
- BMC Musculoskeletal Disorders
- Published
- 2022-05-25
- Volume
- 23
- Issue
- 1
- Pages
- 494-494
- ISSN
- 1471-2474 (ISSN-L)
- PMC
- PMC9131671
- OpenAlex
- W4281493637
- Cited by
- 26
- References
- 32
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 7 · 2023: 4 · 2022: 2
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- BMC Musculoskeletal Disorders (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Nakatomi Foundation
- Japan Society for the Promotion of Science (19K18487)
- Topics
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Health Sciences › Medicine › Surgery › Hip disorders and treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone and Joint Diseases
- Keywords
- monoiodoacetate, hip osteoarthritis, intra-articular injection, animal models of osteoarthritis, radiographic osteoarthritis
- MeSH terms
- Animals, Disease Models, Animal, Humans, Injections, Intra-Articular, Male, Osteoarthritis, Hip, Rats, Sprague-Dawley, Iodoacetic Acid, Osteoarthritis, Knee, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intra-articular injection of monoiodoacetate induces diverse hip osteoarthritis in rats, depending on its dose. https://app.cochat.ai/papers/10.1186/s12891-022-05454-y
- The paper
- Yoh, S., Kawarai, Y., Hagiwara, S., Orita, S., Nakamura, J., Miyamoto, S., Suzuki, T., Akazawa, T., Shiko, Y., Kawasaki, Y., & Ohtori, S. (2022). Intra-articular injection of monoiodoacetate induces diverse hip osteoarthritis in rats, depending on its dose. BMC Musculoskeletal Disorders. https://doi.org/10.1186/s12891-022-05454-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.